Trial Profile
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets in HIV-Positive Children.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 07 Dec 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 05 Apr 2011 Planned end date changed from 1 Dec 2009 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 05 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.